Trials / Unknown
UnknownNCT05890638
Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
A Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to compare the acute bronchodilator effect of the Ipratropium / Levosalbutamol 1.25 mg \& 0.5 mg / 2.5 mL fixed dose combination nebuliser solution or Levosalbutamol 1.25 mg / 3 mL nebuliser solution and Ipratropium 500 mcg nebuliser solution in stable moderate-severe-very severe COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ipratropium / Levosalbutamol Fixed Dose Combination | New combination test treatment |
| DRUG | Ipratropium + Levosalbutamol Free Dose Combination | Free combination control treatment |
Timeline
- Start date
- 2023-08-25
- Primary completion
- 2024-02-06
- Completion
- 2024-03-06
- First posted
- 2023-06-06
- Last updated
- 2023-09-05
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05890638. Inclusion in this directory is not an endorsement.